114 related articles for article (PubMed ID: 6310203)
1. [Tetracosactid (Synacthen) as a therapeutic alternative in uveitis and other chronic inflammations of the eye].
Fricke HJ; Heydenreich A; Thiel U; Schröder D
Klin Monbl Augenheilkd; 1983 Jul; 183(1):10-6. PubMed ID: 6310203
[No Abstract] [Full Text] [Related]
2. [Fatal complication of intravenous administration of synthetic adrenocorticotrophin].
Müller M; Fehm HL; Homoki J; Teller WM
Dtsch Med Wochenschr; 1982 Sep; 107(36):1353-6. PubMed ID: 6288339
[TBL] [Abstract][Full Text] [Related]
3. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].
Kropp R
Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022
[TBL] [Abstract][Full Text] [Related]
4. [Synacthen retard].
Ménégol B; Brard M
Soins; 1985 Apr; (451):I-II. PubMed ID: 3008345
[No Abstract] [Full Text] [Related]
5. [Value of depot synacthen therapy in dermatoses. A report of over 6-years' experiences].
Harnack K; Flegel P
Dermatol Monatsschr; 1984; 170(4):237-43. PubMed ID: 6329833
[No Abstract] [Full Text] [Related]
6. [Drug treatment of inflammatory and infectious endogenous inflammations of the eye].
Witmer R
Klin Monbl Augenheilkd; 1985 Jun; 186(6):424-7. PubMed ID: 3876473
[TBL] [Abstract][Full Text] [Related]
7. Typhoid endotoxin in the treatment of uveitis and other ocular inflammations.
Skrzypczak KE
Am J Ophthalmol; 1967 Nov; 64(5):937-46. PubMed ID: 6054206
[No Abstract] [Full Text] [Related]
8. [Use of Cortrosyn Depot in dermatology].
Aussems J
Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
[No Abstract] [Full Text] [Related]
9. The use of immunosuppressive agents in diseases of the eye.
O'Connor GR
Trans New Orleans Acad Ophthalmol; 1983; 31():378-81. PubMed ID: 6401148
[No Abstract] [Full Text] [Related]
10. [Synthetic ACTH in theumatic diseases: (author's transl)].
Hieber F
MMW Munch Med Wochenschr; 1975 Nov; 117(46):1849-52. PubMed ID: 172785
[TBL] [Abstract][Full Text] [Related]
11. [Analgesic action of tetracosactide in chronic pain syndromes].
Procacci P; Zoppi M; Maresca M; Sereni E
Clin Ter; 1981 Sep; 98(6):643-6. PubMed ID: 6169484
[No Abstract] [Full Text] [Related]
12. [Treatment of uveitis and bacterial endophthalmitis].
de Almeida AA; Ferreira AA; de Freitas JA; de Freitas MM
Rev Bras Oftalmol; 1969; 28(2):81-91. PubMed ID: 5354658
[No Abstract] [Full Text] [Related]
13. Corticotrophin and tetracosactrin depot-self-administered for the treatment of eczema.
Munro DD
Br J Dermatol; 1976 Mar; 94 suppl 12():135-8. PubMed ID: 178340
[TBL] [Abstract][Full Text] [Related]
14. [Importance of the administration of synacthen (beta 1-24 corticotropin) in the therapeutic protocol of patients with neoplasms in an advanced stage].
de Broucker D; Graux P
LARC Med; 1982 Oct; 2(9):806-8. PubMed ID: 6298513
[No Abstract] [Full Text] [Related]
15. [Bialatan in eye infections].
Atienzar
Rev Esp Otoneurooftalmol Neurocir; 1975; 33(196):261-3. PubMed ID: 1230935
[No Abstract] [Full Text] [Related]
16. Steroidstoss therapy in the treatment of herpes zoster.
Sutton G
Br J Clin Pract; 1984 Jan; 38(1):21-4. PubMed ID: 6322830
[No Abstract] [Full Text] [Related]
17. [Tetracosactide in the acute phase of cerebrovascular accidents].
Cornaert P
Lille Med; 1980; 25(7):384-6. PubMed ID: 6253756
[No Abstract] [Full Text] [Related]
18. [Pyrogen therapy in ophthalmology].
Khvoĭnitskiĭ AI
Vestn Oftalmol; 1969; 82(4):80-4. PubMed ID: 5385683
[No Abstract] [Full Text] [Related]
19. Diverticular disease treated with corticotrophin.
Steer C
J R Coll Gen Pract; 1985 Nov; 35(280):532-3. PubMed ID: 3001302
[TBL] [Abstract][Full Text] [Related]
20. [Synacthen depot-induced liver damage in the therapy of secondary generalized epilepsies in childhood].
John K; Gaida P; Kauf E
Padiatr Grenzgeb; 1985; 24(5):391-9. PubMed ID: 2999679
[No Abstract] [Full Text] [Related]
[Next] [New Search]
